HB-700

N/A

Report date: 2026/02/10 20:00:22

Base Information

Drug NameHB-700
Drug Alias NameHB700HB-700
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHookipa Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeoTrail Therapeutics IncF. Hoffmann-La Roche LtdHookipa Pharma Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A